Combined Cataract And Supraciliary Drainage Device Surgery: Short-Term Results
Published 2023 - 41st Congress of the ESCRS
Reference: PP23.03 | Type: Free paper | DOI: 10.82333/5m5x-yw39
Authors: Amir Nassri* 1 , Julien Torbey 1 , Kaweh Mansouri 1
1Glaucoma,Swiss Glaucoma Research Foundation, Swiss Visio,Lausanne,Switzerland
Purpose
To evaluate the reduction of the intraocular pressure (IOP) and the number of anti-glaucomatous medications (AGM) after combined cataract and supraciliary drainage device surgery in patients with uncontrolled open-angle glaucoma.
Setting
This is a single-center, prospective, interventional, single-arm study realized at Swiss Visio Montchoisi, Lausanne.
Methods
Fourteen eyes of 14 patients with primary open-angle glaucoma (POAG) or pseudoexfoliative glaucoma (GPEX) who successfully underwent MINIject® (iSTAR Medical, Wavre, Belgium) implantation in combination with cataract surgery were included. The primary outcome was IOP reduction at 1 week, 1 and 3 months. Complete success was defined as more than 20% IOP reduction from baseline, absolute IOP measurements below 21 mmHg at all time points, and no AGMs. Relative success corresponded to a reduction in IOP of less than 20% without AGMs.
Results
Mean baseline IOP was 16.8±4.0 mmHg on 2.4±1.0 AGMs. At 1 week, 1 and 3 months after surgery, mean IOP was at 11.4±4.3 mmHg, 13.4±3.2 mmHg and 12.5±4.2 mmHg, respectively, corresponding to a reduction of 47.4% (p=0,003), 25.4% (p=0,026) and 34.4% (p=0,125) from baseline. At 3 months, no patients were on AGMs. At 1 week, 1 and 3 months after surgery, complete success was obtained in 70.0%, 55.6% and 62.5% of patients. Mean visual acuity before surgery was 0.7±0.2. At 1 week, 1 and 3 month, mean visual acuity was 0.8±0.2, 0.9±0.1 and 0.95±0.15, respectively. The main postoperative complication was a self-limiting hematic tyndall. One case of corneal edema was noted which resolved spontaneously. No serious adverse effects were observed.
Conclusions